BLRX - BioLineRx Ltd. (BLRX) CEO Philip Serlin on Q2 2021 Results - Earnings Call Transcript

BioLineRx Ltd. (BLRX) Q2 2021 Earnings Conference Call August 18, 2021, 10:00 AM ET Company Participants Tim McCarthy - LifeSci Advisors, IR Philip Serlin - Chief Executive Officer Mali Zeevi - Chief Financial Officer Abi Vainstein-Haras - Chief Medical Officer Ella Sorani - Chief Development Officer Conference Call Participants Joe Pantginis - HC Wainwright Mark Breidenbach - Oppenheimer Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Second Quarter 2021 Results Conference Call. All participants are presently in a listen-only mode. Following management’s formal presentation, instructions will be given for the question-and-answer session [Operator Instruction] I would now like to turn over the call to Tim McCarthy of LifeSci Advisors. Please go ahead. Tim McCarthy Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. All statements in this conference call other than historical

For further details see:

BioLineRx Ltd. (BLRX) CEO Philip Serlin on Q2 2021 Results - Earnings Call Transcript